Recombinant hepatitis B vaccine and the risk of multiple sclerosis: A prospective study

Neurology

Volumn 63, Issue 5, 2004, Pages 838-842

  Hernán, Miguel A ^a   Jick, Susan S ^b   Olek, Michael J ^c   Jick, Hershel ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BOSTON UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT HEPATITIS B VACCINE;

ADULT; AGE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; EXAMINATION; FEMALE; GENDER; GENERAL PRACTICE; HUMAN; IMMUNIZATION; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIPLE SCLEROSIS; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RECORDING; RISK; SYMPTOM; TETANUS PROPHYLAXIS; UNITED KINGDOM; VACCINATION;

EID: 4644271806     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000138433.61870.82     Document Type: Article

References (21)

1. Kane M, Clements J, Hu D. Hepatitis B. In: Jamison DT, Mosley WH, Measham AR, Bobadilla JL, eds. Disease control priorities in developing countries. New York: Oxford University Press, 1993;321-330.
2. Dittmann S. Special address: safety of hepatitis B vaccination. Vaccine 2000;18:S10-S11.
3. Viral Hepatitis Prevention Board. Meeting report. Multiple sclerosis and hepatitis B vaccine? Vaccine 1999;17:2473-2475,
4. Fourrier A, Bégaud B, Alpérovitch A, et al. Hepatitis B vaccine and first episodes of central nervous system demyelinating disorders: a comparison between reported and expected number of cases. Br J Clin Pharmacol 2001;51:489-490.
5. Touzé E, Gout O, Verdier-Taillefer MH, Lyon-Caen O, Alpérovitch A. Premier épisode de démyélinisation du système nerveux central et vaccination contre l'hépatite B: etude cas-témoins pilote. Rev Neurol 2000; 156:242-246.
6. Touzé E, Fourrier A, Rue-Fenouche C, et al. Hepatitis B vaccination and first central nervous system demyelinating event: a case-control study. Neuroepidemiology 2002;21:180-186.
7. Sturkenboom MCJM. Vaccinations, Demyelination, and Multiple Sclerosis Study (VDAMS). A population-based study in the UK. Pharmacoepidemiol Drug Saf 1999;8(suppl 2):S170-171.
8. DeStefano F, Verstraeten T, Jacksin LA, et al. Vaccinations and risk of central nervous system demyelinating diseases in adults. Arch Neurol 2003;60:504-509.
9. Ascherio A, Zhang SM, Hernán MA, et al. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 2001;344:327-332.
10. Zipp F, Weil JG, Einhäupl KM. No increase in demyelinating diseases after hepatitis B vaccination. Nat Med 1999;5:964-965.
11. Sadovnick AD, Scheifele DW. School-based hepatitis B vaccination programme and adolescent multiple sclerosis. Lancet 2000;355:549-550.
12. García Rodríguez LA, Pérez Gutthann S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 1998;45:419-425.
13. Jick H, Jick S, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991;302:766-768.
14. Jick SS, Kaye JA, Vasilakis-Scaramozza C, et al. Validity of the General Practice Research Database. Pharmacotherapy 2003;23:686-689.
15. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
16. McDonald W, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-127.
17. Poser CM, The epidemiology of multiple sclerosis: a general overview. Ann Neurol 1994;36(S2):S180-193.
18. Bégaud B, Alpérovitch A. Vaccinations and multiple sclerosis. N Engl J Med 2001;344:1793. Letter.
19. Sturkenboom MCJM, Fourrier A. Vaccinations and multiple sclerosis. N Engl J Med 2001;344:1794. Letter.
20. Ascherio A, Zhang SM, Walker AM. Vaccinations and multiple sclerosis. N Engl J Med 2001;344:1795. Letter.
21. Institute of Medicine. Hepatitis B vaccine and demyelinating neurological disorders. In: Stratton K, Almario DA, McCormick MC, eds. Immunization safety review. Washington, DC: The National Academies Press, 2002.